Bioventus (NSDQ:BVS) this week announced that its stockholders approved the merger and acquisition of Misonix for an undisclosed amount. The Durham, N.C.–based orthobiologics company’s stockholders approved the issuance of shares of Bioventus class A common stock to the stockholders of Misonix for the previously announced merger of the two companies. Through the deal, Misonix will become […]
